Scandion Oncology (SCOL)

Nasdaq First North Growth Market Sweden | Biotech | Oncology/biotech
Intro rate Introductory pricing for early customers through June 30 — the same full analysis at a lower rate while we refine delivery.
Free
No email, no account, no signup.
Pulling latest news for Scandion Oncology…
Bull
Bear
Intro rate Introductory pricing for early customers through June 30 — the same full analysis at a lower rate while we refine delivery.

Professional stock analysis at introductory pricing. 7-day money-back guarantee — no lock-in.

Want the why behind the signal? Get the deep 4-model report — full bull/bear, dated catalysts, dilution risk, weekly refresh. $4.99 $1.25.
Get the deep 4-model report – $4.99 $1.25
Signal
SELL
Sentiment
N/A/10
Risk
10/10
Get full analysis with Bull/Bear case, catalysts, and risk analysis
Buy express analysis – $4.99 $1.25
7-day money-back guarantee · No lock-in period · Secure payment via Stripe
Extremely negative sentiment; discussion centered on liquidation, delisting, and likely zero recovery. Very limited chatter after delisting.
Exchange
Nasdaq First North Growth Market Sweden
Type
Biotech
Sector
Oncology/biotech
Market Cap
$2M

Fresh 27 Jun 2026

Market sentiment

Extremely negative sentiment; discussion centered on liquidation, delisting, and likely zero recovery. Very limited chatter after delisting.

Why SELL ?

- **Delisted** and in liquidation → very limited investability. - High likelihood of **no** liquidation distribution to shareholders. - No operating pipeline/financing left to drive value.
  • Reduce/exit if possible; otherwise treat as a loss position and monitor the liquidator’s final notice.

Recent News

  • No new press releases or verifiable company-specific updates have been identified since 2026-06-26. The company is still assessed as delisted (last trading day 11 July 2025) and in voluntary liquidation with no communicated new catalysts.

Bull case

- **Possible** small recovery if liquidation leaves surplus (unlikely). - Costs decline as operations wind down.
Unlock to read more →

Bear case

- Shares are **delisted** and effectively illiquid.
Unlock to read more →

Dilution Risk

Assessment: Low

Order analysis – $4.99 $1.25
Save hours of research. $4.99 $1.25.
Not satisfied? Get your money back within 7 days — no questions asked.
7-day money-back guarantee · No lock-in period · Secure payment via Stripe
Intro rate Introductory pricing for early customers through June 30 — the same full analysis at a lower rate while we refine delivery.

Want to read the full analysis?

Order a fresh analysis of Scandion Oncology – ready in your inbox in 5–15 minutes.

  • Signal + risk + sentiment
  • Bull/Bear case + triggers
  • Catalysts with dates
  • Saved as a webpage in your account
  • Ready in 5–15 min (email when ready)

Full analysis at introductory pricing — 7-day money-back guarantee.

7-day money-back guarantee · No lock-in period · Secure payment via Stripe

Fact-based analysis Updated weekly No commitment period
Scandion Oncology (SCOL)
SELL
Buy express analysis – $4.99 $1.25
The information on this page does not constitute investment advice. AI-generated analyses may contain errors. Always conduct your own research before making investment decisions. Firelda.ai is not responsible for any potential losses.